Gritstone bio, Inc. Common Stock
GRTS
GRTS was delisted on the 21st of October, 2024.
69 hedge funds and large institutions have $60.3M invested in Gritstone bio, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 28 reducing their positions, and 25 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
15% less funds holding
Funds holding: 81 → 69 (-12)
43% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 28
48% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 25
69% less capital invested
Capital invested by funds: $194M → $60.3M (-$133M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$734K |
| 2 |
D.E. Shaw & Co
New York
|
+$665K |
| 3 |
Walleye Capital
New York
|
+$639K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$504K |
| 5 |
Walleye Trading
New York
|
+$314K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Casdin Capital
New York
|
-$12.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.2M |
| 3 |
PS
Peter Svennilson
|
-$3.09M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.47M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$2.33M |
GRTS Hedge Fund Activity: Q3 2020 in Review
69 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q3 2020, worth a combined $60.3M — down 69% from $194M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of GRTS and 13 opened new positions — a net loss of 12 holders — while 28 trimmed existing stakes and 16 added.
The largest buyer was Renaissance Technologies, adding an estimated $734K. The largest seller was Casdin Capital, exiting entirely with an estimated $12.3M sold.
- 69 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q3 2020, down from 81 in Q2 2020.
- Funds reported $60.3M of Gritstone bio, Inc. Common Stock stock for Q3 2020, down 69% quarter-over-quarter.
- 13 funds opened new Gritstone bio, Inc. Common Stock positions in Q3 2020 and 25 closed out, a net change of -12 holders.
- The largest Gritstone bio, Inc. Common Stock buyer in Q3 2020 was Renaissance Technologies, an estimated $734K added.
- The largest Gritstone bio, Inc. Common Stock seller in Q3 2020 was Casdin Capital, an estimated $12.3M sold.
Based on aggregated 13F filings for Q3 2020.